Abstract:Background: The ability of a tumor to become dormant in response to suboptimal conditions has recently been recognized as a key step in tumor progression. Tumor dormancy has been found to be implicated in several tumor types as the culprit of therapy resistance and metastasis development, the deadliest features of a cancer. Several lines of evidence indicate that the development of these traits may rely on the de-differentiation of committed tumor cells that regain stem-like properties during a dormant state. Presently, dormancy is classified into cell- and population-level, according to the preponderance of cellular mechanisms that keep tumor cells quiescent or to a balance between overall cell division and death, respectively. Cellular dormancy is characterized by autophagy, stress-tolerance signaling, microenvironmental cues and, of prime relevance, epigenetic modifications. It has been found that the epigenome alters during cellular quiescence, thus representing the driving force for short-term cancer progression. Population-level dormancy is characterized by processes that counteract proliferation, such as inappropriate blood supply and intense immune responses. The latter two mechanisms are not mutually exclusive and may affect tumor masses both simultaneously and subsequently. Conclusions: Overall, tumor dormancy may represent an additional step in the acquisition of cancer characteristics, and its comprehension may clarify both theoretical and practical aspects of cancer development. Clinically, only a deep understanding of dormancy may explain the course of tumor development in different patients, thus representing a process that may be targeted to prevent and/or treat advanced-stage cancers. That is especially the case for breast cancer, against which the mTOR inhibitor everolimus displays potent antitumor activity in patients with metastatic disease by impeding autophagy and tumor dormancy onset. Here we will also discuss other targeted therapies directed towards tumor dormancy onset, e.g. specific inhibitors of SFK and MEK, or aimed at keeping tumor cells dormant, e.g. prosaposin derivatives, that may shortly enter clinical assessment in breast, and possibly other cancer types.

From ecology to oncology: To understand cancer stem cell dormancy, ask a Brine shrimp (<i>Artemia</i>)

From ecology to oncology: To understand cancer stem cell dormancy, ask a Brine shrimp (Artemia)

Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting

The Relationship Between Mesenchymal Stem Cells and Tumor Dormancy

SET Domain-Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence

DEK Terminates Diapause by Activation of Quiescent Cells in the Crustacean Artemia.

SETD4 Regulates Cell Quiescence and Catalyzes the Trimethylation of H4K20 During Diapause Formation in Artemia

Cell Dormancy and Tumor Refractory

Colorectal cancer cell dormancy: An insight into pathways

Downregulation of a CT10 Regulator of Kinase (crk) Promotes the Formation of Diapause Embryos in the Brine Shrimp Artemia.

Unveiling cancer dormancy: Intrinsic mechanisms and extrinsic forces

Revealing role of epigenetic modifiers and DNA oxidation in cell-autonomous regulation of Cancer stem cells

Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications

Mechanisms of disseminated cancer cell dormancy: an awakening field

The Chloride Channel Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Controls Cellular Quiescence by Hyperpolarizing the Cell Membrane During Diapause in the Crustacean Artemia.

Tumor Dormancy Within the Lymphovascular Embolus Is Regulated by Multiple Metabolism-signaling Pathways

Natural Killer Cell Regulation of Breast Cancer Stem Cells Mediates Metastatic Dormancy

Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis.

Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution

Involvement of p90 Ribosomal S6 Kinase in Termination of Cell Cycle Arrest during Development of Artemia-encysted Embryos

The Evolutionary Ecology of Dormancy in Nature and in Cancer